Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | NPY2R | P49146 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | BCR | P11274 | 1/20 | 0.38 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6137337 | 0.87 | MEN1 (0.43) | SLC9A1CYP3A4CYP2C19NPY2RHTT | |
| SCHEMBL6137207 | 0.84 | SLC9A1 (0.62) | SLC9A1CYP3A4CYP2C19NPY2RGAA | |
| SCHEMBL6137327 | 0.84 | ALDH1A1 (0.47) | SLC9A1CYP3A4CYP2C19POLBHTT | |
| SCHEMBL27488943 | 0.81 | SLC9A1 (0.45) | SLC9A1CYP3A4CYP2C19NPY2RPOLB | |
| SCHEMBL7985443 | 0.78 | SLC9A1 (0.51) | SLC9A1CYP3A4CYP2C19NPY2R | |
| SCHEMBL7982517 | 0.76 | RBP4 (0.54) | SLC9A1CYP3A4CYP2C19NPY2RPOLB | |
| SCHEMBL27488942 | 0.74 | SLC9A1 (0.52) | SLC9A1CYP3A4CYP2C19NPY2R | |
| SCHEMBL8767676 | 0.71 | CES2 (0.47) | POLBGAA | |
| SCHEMBL7061443 | 0.70 | SLC9A1 (0.57) | SLC9A1POLBHPGDGAAMAPT | |
| Hydrochloric Acid SCHEMBL6137329 | 0.69 | NPY2R (0.51) | SLC9A1CYP3A4CYP2C19NPY2RPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1165534-B1 | BENZOYLGUANIDINE DERIVATIVES WITH ADVANTAGEOUS PROPERTIES, METHOD FOR PRODUCING THEM AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA (DE) | 2005-02-02 | — | — | EP | disclosed |
| EP-1165534-A2 | BENZOYLGUANIDINE DERIVATIVES WITH ADVANTAGEOUS PROPERTIES, METHOD FOR PRODUCING THEM AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS | Boehringer Ingelheim Pharma KG (DE) | 2002-01-02 | — | — | EP | disclosed |
| US-6323207-B1 | TREATMENT OR REDUCTION OF TISSUE DAMAGE DUE TO ISCHAEMIA WHICH COMPRISES ADMINISTERING TO A HOST SUFFERING FROM ISCHAEMIA | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2001-11-27 | — | — | US | disclosed |
| WO-2000017176-A2 | BENZOYLGUANIDINE DERIVATIVES WITH ADVANTAGEOUS PROPERTIES, METHOD FOR PRODUCING THEM AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2000-03-30 | — | — | WO | disclosed |